Investigating the Effect of Dexmedetomidine in Controlling Postoperative Emergence Agitation in Children under

Mitra Golmohammadi1, Shahryar Sane1, Somayeh Ghavipanjeh Rezaei2

  • 1Department of Anesthesiology Urmia University of Medical Sciences, Urmia, Iran.

Insights

Dexmedetomidine significantly reduced emergence agitation (EA) and pain in children after anesthesia. However, it may delay emergence from anesthesia, requiring careful consideration of its use.

Area of Science:

  • Anesthesiology
  • Pediatric Surgery
  • Pharmacology

Background:

  • Emergence agitation (EA) is a common complication following general anesthesia in children.
  • Sevoflurane anesthesia is frequently used in pediatric procedures, but can be associated with EA.

Purpose of the Study:

  • To investigate the efficacy of dexmedetomidine in controlling emergence agitation in children.
  • To assess the impact of dexmedetomidine on pain, analgesic consumption, and side effects during emergence from sevoflurane anesthesia.

Main Methods:

  • A randomized, double-blind, placebo-controlled trial involving 76 children aged 2-7 years undergoing elective adenoidectomy/tonsillectomy.
  • Patients received either dexmedetomidine (0.5 μg/kg) or placebo (normal saline) infusion ten minutes after intubation.
  • Agitation was assessed using a four-point scale, and pain was evaluated with the FLACC scale.

Main Results:

  • Dexmedetomidine significantly reduced agitation and pain scores in the Post Anesthesia Care Unit (PACU), except at 40 minutes post-PACU admission.
  • Analgesic (pethidine) and antiemetic (metoclopramide) use was lower in the dexmedetomidine group.
  • Increased incidence of shivering and hypotension requiring intervention was observed in the dexmedetomidine group compared to placebo.

Conclusions:

  • A perioperative infusion of 0.5 μg/kg dexmedetomidine effectively reduces emergence agitation, pain, and postoperative nausea and vomiting in children.
  • Dexmedetomidine administration may lead to delayed emergence from anesthesia.
  • The findings support dexmedetomidine as a potential agent for managing EA, balanced against potential delays in recovery.
Abstract

Related Concept Videos

Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
111
Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
240
Stages of General Anesthesia01:22

Stages of General Anesthesia

Various sedation levels offer significant advantages in facilitating procedural interventions for patients undergoing medical or invasive surgical procedures. These levels span from anxiolysis to general anesthesia, providing a spectrum of sedative effects to cater to specific patient needs. Anxiolysis reduces anxiety and is achieved through minimal sedation, enabling patients to remain awake and responsive while feeling more at ease during the procedure. This level can benefit minor...
399
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
349
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
316
General Anesthesia: Overview01:24

General Anesthesia: Overview

Anesthesia is a medical procedure that uses drugs for CNS suppression to enable painless surgeries and procedures. The selection of anesthetics is influenced by their pharmacokinetic properties, side effects, and patient characteristics. Various types of anesthesia include general, local, regional, spinal, and inhalational.
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
199